“Treatment of relapsed/refractory CLL with Venetoclax-Rituximab during the COVID-19 pandemic: A daily-life experience in southern Italy”. (2021) Mediterranean Journal of Hematology and Infectious Diseases, 13(1), p. e2021042. doi:10.4084/MJHID.2021.042.